product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
BID Antibody (Mouse Specific)
catalog :
2003
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunohistochemistry
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 8
Thangaraj K, Balasubramanian B, Park S, Natesan K, Liu W, Manju V. Orientin Induces G0/G1 Cell Cycle Arrest and Mitochondria Mediated Intrinsic Apoptosis in Human Colorectal Carcinoma HT29 Cells. Biomolecules. 2019;9: pubmed publisher
  • western blot; mouse; loading ...; fig s3i
He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed publisher
  • immunohistochemistry; mouse; loading ...; fig 3b
Li J, Chen K, Li S, Liu T, Wang F, Xia Y, et al. Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis. PLoS ONE. 2016;11:e0152570 pubmed publisher
product information
SKU :
2003S
Product-Name :
BID Antibody (Mouse Specific)
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
M
Applications :
Western blot
Product-Category :
Apoptosis
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
22
Host :
Rabbit
Target :
Bid mouse
Primary-Protein :
Bid
Alt-Names :
2700049M22Rik,AI875481,AU022477,BH3 interacting domain death agonist,BH3-interacting domain death agonist,BH3-interacting domain death agonist p11,BH3-interacting domain death agonist p13,BH3-interacting domain death agonist p15,BID,OTTMUSP00000028756,p11 BID,p13 BID,p15 BID,p22 BID
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.